These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
706 related articles for article (PubMed ID: 16729554)
1. Epidemiology and natural history of genital human papillomavirus infection. Weaver BA J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Broomall EM; Reynolds SM; Jacobson RM Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Villa LL Vaccine; 2006 Mar; 24 Suppl 1():S23-8. PubMed ID: 16194583 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus: the burden of infection. Wiley D; Masongsong E Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S3-14. PubMed ID: 16729902 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology and natural history of HPV. Cox JT J Fam Pract; 2006 Nov; Suppl():3-9. PubMed ID: 17366752 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus and genital cancer. Rapose A Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. Paavonen J Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus, cervical cancer, and the vaccines. Tovar JM; Bazaldua OV; Vargas L; Reile E Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072 [TBL] [Abstract][Full Text] [Related]
10. Vaccines for preventing HPV-related anogenital infection and neoplasia. Ferris DG J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S9-13. PubMed ID: 16729555 [TBL] [Abstract][Full Text] [Related]
11. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines. Hampl M Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854 [TBL] [Abstract][Full Text] [Related]
12. [Vaccination against human papillomavirus for the prevention of cervical cancer]. Quint WG; ter Harmsel WA; van Doorn LJ Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585 [TBL] [Abstract][Full Text] [Related]
14. Prevention strategies against the human papillomavirus: the effectiveness of vaccination. Stanley M Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology of mucosal human papillomavirus infection and associated diseases. Trottier H; Burchell AN Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442 [TBL] [Abstract][Full Text] [Related]
17. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Forcier M; Musacchio N Dermatol Ther; 2010; 23(5):458-76. PubMed ID: 20868401 [TBL] [Abstract][Full Text] [Related]
18. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18. Goldstone SE; Vuocolo S Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023 [TBL] [Abstract][Full Text] [Related]
19. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US. Dunne EF; Datta SD; E Markowitz L Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283 [TBL] [Abstract][Full Text] [Related]
20. Vaccination as a prevention strategy for human papillomavirus-related diseases. Kahn JA J Adolesc Health; 2005 Dec; 37(6 Suppl):S10-6. PubMed ID: 16310136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]